Literature DB >> 19912528

Molecular cloning and transcriptional analysis of a newly identified anti-lipopolysaccharide factor gene in kuruma shrimp, Marsupenaeus japonicus.

T Mekata1, R Sudhakaran, S Okugawa, T Kono, M Sakai, T Itami.   

Abstract

AIM: In the present study, we have cloned a new family of anti-lipopolysaccharide factor (ALF) from haemocytes of kuruma shrimp Marsupenaeus japonicus (MjALF2) using RACE method. METHODS AND
RESULTS: Transcriptional analysis of MjALF2 gene in the organs of healthy shrimp revealed prominent expression in gills and muscle. In vitro LPS stimulation in the lymphoid organ cells resulted in significant increase in expression at 48, 8 and 12 h poststimulation, compared to the nonstimulated cells. In vivo injection of V. penaeicida does not show any high expression in time course assay. Phylogenetic analysis showed MjALF2 is placed in the group closer to P. monodon isoform 1 and 2 than to MjALF1. The full-length MjALF2 gene consists of 558 bp with a 363 -bp open reading frame, encoding 121 amino acids. The deduced peptide contains a putative signal peptide of 22 amino acids with molecular mass of about 13.8 kDa molecular mass. The deduced amino acid sequence of MjALF2 showed 83.3 and 56.7% identity with ALF sequences of P. monodon.
CONCLUSIONS: The present work revealed the presence of MjALF2 gene, which is highly expressed in gills and muscle of healthy kuruma shrimp. Further studies are required to clarify the involvement of MjALF2 in immune responses for using as a therapeutic agent. SIGNIFICANCE AND IMPACT OF THE STUDY: Antimicrobial peptides are promising potential therapeutic agents for disease control in aquaculture. Understanding the relation of MjALF2 with innate immunity mechanism will lead to develop better health management strategies for long-term sustainability of the shrimp industry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19912528     DOI: 10.1111/j.1472-765X.2009.02763.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  7 in total

Review 1.  Cationic antimicrobial peptides in penaeid shrimp.

Authors:  Anchalee Tassanakajon; Piti Amparyup; Kunlaya Somboonwiwat; Premruethai Supungul
Journal:  Mar Biotechnol (NY)       Date:  2010-04-09       Impact factor: 3.619

Review 2.  Cationic antimicrobial peptides in penaeid shrimp.

Authors:  Anchalee Tassanakajon; Piti Amparyup; Kunlaya Somboonwiwat; Premruethai Supungul
Journal:  Mar Biotechnol (NY)       Date:  2011-05-02       Impact factor: 3.619

Review 3.  The role of biophysical parameters in the antilipopolysaccharide activities of antimicrobial peptides from marine fish.

Authors:  Ramamourthy Gopal; Chang Ho Seo; Yoonkyung Park
Journal:  Mar Drugs       Date:  2014-03-13       Impact factor: 5.118

Review 4.  Marine Arthropods as a Source of Antimicrobial Peptides.

Authors:  Juan Pablo Saucedo-Vázquez; Fernando Gushque; Nelson Santiago Vispo; Jenny Rodriguez; Marco Esteban Gudiño-Gomezjurado; Fernando Albericio; Markus P Tellkamp; Frank Alexis
Journal:  Mar Drugs       Date:  2022-08-02       Impact factor: 6.085

5.  Anti-lipopolysaccharide Factor from Crucifix Crab Charybdis feriatus, Cf-ALF2: Molecular Cloning and Functional Characterization of the Recombinant Peptide.

Authors:  K S Sruthy; Rosamma Philip
Journal:  Probiotics Antimicrob Proteins       Date:  2020-11-11       Impact factor: 4.609

6.  Single-cell RNA-seq analysis reveals penaeid shrimp hemocyte subpopulations and cell differentiation process.

Authors:  Keiichiro Koiwai; Takashi Koyama; Soichiro Tsuda; Atsushi Toyoda; Kiyoshi Kikuchi; Hiroaki Suzuki; Ryuji Kawano
Journal:  Elife       Date:  2021-06-16       Impact factor: 8.140

7.  Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.

Authors:  Rafael Diego Rosa; Agnès Vergnes; Julien de Lorgeril; Priscila Goncalves; Luciane Maria Perazzolo; Laure Sauné; Bernard Romestand; Julie Fievet; Yannick Gueguen; Evelyne Bachère; Delphine Destoumieux-Garzón
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.